Open AccessLong-term safety, efficacy, treatment satisfaction, and impact on healthcare service use of paliperidone palmitate one-month intramuscular formulation in patients with recent-onset schizophrenia in taiwan: A subgroup analysis of an asia-pacific, 18-month, phase 3b study
Author(s) -
Tze-Chun Tang,
MingHong Hsieh,
Chen-Chung Liu,
NanYing Chiu,
Fong-Lin Jang,
ChihLin Chiang,
TungPing Su
Publication year - 2019
Publication title -
taiwanese journal of psychiatry/táiwān jīngshén yīxué
Language(s) - English
Resource type - Journals
eISSN - 2666-2078
pISSN - 1028-3684
DOI - 10.4103/tpsy.tpsy_39_19
Subject(s) - paliperidone palmitate , paliperidone , medicine , schizophrenia (object oriented programming) , subgroup analysis , psychiatry , risperidone , meta analysis